During the AOA’s 2025 House of Delegates meeting, director of the AOA’s clinical resources group, Andrew Morgenstern, OD, announced the report, “Glucagon-like Peptide-1 Receptor Agonists and Ocular Health: Guidance for Optometric Practice.”
Optometric Management
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
In a phase III trial (ROSELLA) reported in The Lancet, Olawaiye et al examined the survival benefit of adding relacorilant to nab-paclitaxel in women with platinum-resistant ovarian cancer. Relacorila...
New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.